Stephan D - Search Results

1

Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.

Stephan D, Winkler M, Kühner P, Russ U, Quast U. Stephan D, et al. Diabetologia. 2006 Sep;49(9):2039-48. doi: 10.1007/s00125-006-0307-3. Epub 2006 Jul 25. Diabetologia. 2006. PMID: 16865362

2

Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.

Russ U, Kühner P, Prager R, Stephan D, Bryan J, Quast U. Russ U, et al. Among authors: stephan d. Br J Pharmacol. 2009 Jan;156(2):354-61. doi: 10.1111/j.1476-5381.2008.00005.x. Epub 2009 Jan 13. Br J Pharmacol. 2009. PMID: 19154434 Free PMC article.

3

The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.

Quast U, Stephan D, Bieger S, Russ U. Quast U, et al. Among authors: stephan d. Diabetes. 2004 Dec;53 Suppl 3:S156-64. doi: 10.2337/diabetes.53.suppl_3.s156. Diabetes. 2004. PMID: 15561904 Review.

4

The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Stephan D, Stauss E, Lange U, Felsch H, Löffler-Walz C, Hambrock A, Russ U, Quast U. Stephan D, et al. Br J Pharmacol. 2005 Apr;144(8):1078-88. doi: 10.1038/sj.bjp.0706142. Br J Pharmacol. 2005. PMID: 15711591 Free PMC article.

5

Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U. Winkler M, et al. Among authors: stephan d. J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. doi: 10.1124/jpet.107.123224. Epub 2007 May 10. J Pharmacol Exp Ther. 2007. PMID: 17495126

6

Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel.

Kühner P, Prager R, Stephan D, Russ U, Winkler M, Ortiz D, Bryan J, Quast U. Kühner P, et al. Among authors: stephan d. Naunyn Schmiedebergs Arch Pharmacol. 2012 Mar;385(3):299-311. doi: 10.1007/s00210-011-0709-8. Epub 2011 Nov 15. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22083559

7

KATP channel openers of the benzopyran type reach their binding site via the cytosol.

Stephan D, Salamon E, Weber H, Russ U, Lemoine H, Quast U. Stephan D, et al. Br J Pharmacol. 2006 Sep;149(2):199-205. doi: 10.1038/sj.bjp.0706858. Epub 2006 Aug 14. Br J Pharmacol. 2006. PMID: 16921394 Free PMC article.

8

Lipids modulate ligand binding to sulphonylurea receptors.

Klein A, Lichtenberg J, Stephan D, Quast U. Klein A, et al. Among authors: stephan d. Br J Pharmacol. 2005 Aug;145(7):907-15. doi: 10.1038/sj.bjp.0706252. Br J Pharmacol. 2005. PMID: 15895108 Free PMC article.

9

A reflection on frustrated Lewis pairs 20 years on: the gift that keeps on giving.

Melen RL, Stephan DW. Melen RL, et al. Among authors: stephan dw. Chem Sci. 2025 Sep 24. doi: 10.1039/d5sc90195b. Online ahead of print. Chem Sci. 2025. PMID: 41000130 Free PMC article.

10

Thrombotic storm with paradoxical embolism in ovarian clear cell carcinoma.

Cordeanu EM, Mirea C, Brouder S, Zamperini C, Ploncard O, Stephan D. Cordeanu EM, et al. Among authors: stephan d. Vasc Dis (Paris). 2025 Sep 23:S3050-6581(25)00256-0. doi: 10.1016/j.vasdi.2025.09.001. Online ahead of print. Vasc Dis (Paris). 2025. PMID: 40992951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

848 results

Search Page

Filters